Adaptive Biotechnologies
Hui Huang possesses extensive experience in molecular assay development, bioinformatics, and diagnostic product development. Currently serving as a Senior Scientist at Adaptive Biotechnologies Corp., Hui Huang focuses on NGS Molecular Product Development and Quality Control, having developed innovative molecular assays and bioinformatics tools while also advancing quality control processes. Prior to this role, Hui Huang spent over a decade at Immucor, Inc., contributing to surface chemistry innovations and immunoassay developments, resulting in two patent filings. Earlier career experience includes efforts at Bioarray Solutions Ltd., where Hui Huang co-invented a BeadChip assay platform that achieved FDA approval. Hui Huang holds a Ph.D. in Chemistry from the University of Michigan and a Bachelor's Degree in Chemistry from Peking University.
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.